Abstract:Mitochondria are a major site of intracellular reactive oxygen species (ROS) production. Under physiological conditions, 0.2%–2% of electrons in the mitochondrial electron transport chain (ETC) leak out of the ETC and interact with oxygen to produce superoxide and H2O2. In addition, NADPH oxidase (NOX4) is up‐regulated in senescent cells, which can increase the production of ROS. In degenerative IVD, the levels of cell senescence and mitochondrial dysfunction increase, which contribute to the abnormal increase of intracellular ROS level. At the same time, ROS is also an important factor leading to cell senescence and mitochondrial dysfunction, which forms a positive feedback loop. Disturbance of redox status in degenerative IVD manifests as increased ROS production on the one hand, and decreased expression levels and activities of antioxidant substances on the other hand. Therefore, the imbalance of ROS production and scavenging in degenerative IVD leads to the disturbance of redox status, which causes oxidative damage to intracellular biomacromolecules and subsequent cellular dysfunction. Low back pain (LBP) is a leading cause of labour loss and disability worldwide, and it also imposes a severe economic burden on patients and society. Among symptomatic LBP, approximately 40% is caused by intervertebral disc degeneration (IDD). IDD is the pathological basis of many spinal degenerative diseases such as disc herniation and spinal stenosis. Currently, the therapeutic approaches for IDD mainly include conservative treatment and surgical treatment, neither of which can solve the problem from the root by terminating the degenerative process of the intervertebral disc (IVD). Therefore, further exploring the pathogenic mechanisms of IDD and adopting targeted therapeutic strategies is one of the current research hotspots. Among the complex pathophysiological processes and pathogenic mechanisms of IDD, oxidative stress is considered as the main pathogenic factor. The delicate balance between reactive oxygen species (ROS) and antioxidants is essential for maintaining the normal function and survival of IVD cells. Excessive ROS levels can cause damage to macromolecules such as nucleic acids, lipids, and proteins of cells, affect normal cellular activities and functions, and ultimately lead to cell senescence or death. This review discusses the potential role of oxidative stress in IDD to further understand the pathophysiological processes and pathogenic mechanisms of IDD and provides potential therapeutic strategies for the treatment of IDD.

Polyphenols as Potential Antioxidants for the Treatment of Intervertebral Disc Degeneration.

Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals

Oxidative Stress and Intervertebral Disc Degeneration: Pathophysiology, Signaling Pathway, and Therapy

Cell Senescence: A Nonnegligible Cell State under Survival Stress in Pathology of Intervertebral Disc Degeneration

The Role of Oxidative Stress in Intervertebral Disc Degeneration

Moderate Alcohol Consumption May Decrease Risk of Intervertebral Disc Degeneration

Innovative immune mechanisms and antioxidative therapies of intervertebral disc degeneration

Oxidative stress in intervertebral disc degeneration: Molecular mechanisms, pathogenesis and treatment

The Anti-Oxidation Related Bioactive Materials for Intervertebral Disc Degeneration Regeneration and Repair

Tea Polyphenol Attenuates Oxidative Stress-Induced Degeneration of Intervertebral Discs by Regulating the Keap1/Nrf2/ARE Pathway.

ROS: Crucial Intermediators in the Pathogenesis of Intervertebral Disc Degeneration

The Nrf2 antioxidant defense system in intervertebral disc degeneration: Molecular insights

Dietary polyphenols as a safe and novel intervention for modulating pain associated with intervertebral disc degeneration in an in-vivo rat model

Honokiol Alleviates the Degeneration of Intervertebral Disc Via Suppressing the Activation of TXNIP-NLRP3 Inflammasome Signal Pathway.

Aging, cell senescence, the pathogenesis and targeted therapies of intervertebral disc degeneration

Role of Advanced Glycation End Products in Intervertebral Disc Degeneration: Mechanism and Therapeutic Potential

The role of ageing and oxidative stress in intervertebral disc degeneration

Pharmacological Effects of Resveratrol in Intervertebral Disc Degeneration: A Literature Review

Cell and Molecular Biology of Intervertebral Disc Degeneration: Current Understanding and Implications for Potential Therapeutic Strategies

Rebalance of the Polyamine Metabolism Suppresses Oxidative Stress and Delays Senescence in Nucleus Pulposus Cells

Regulatory Effect of Inflammatory Mediators in Intervertebral Disc Degeneration